| P50 | author | Heather Whitaker | Q42800093 |
| | Matthew Donati | Q59770707 |
| | Maria Zambon | Q91506671 |
| | Nick Andrews | Q91506784 |
| P2093 | author name string | Richard Pebody | |
| | Joanna Ellis | |
| | Hongxin Zhao | |
| P2860 | cites work | Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis | Q28067038 |
| | A new laboratory-based surveillance system (Respiratory DataMart System) for influenza and other respiratory viruses in England: results and experience from 2009 to 2012. | Q30358501 |
| | Mid-Season Estimates of Influenza Vaccine Effectiveness against Influenza A(H3N2) Hospitalization in the Elderly in Quebec, Canada, January 2015 | Q35705382 |
| | Statistical foundations for model-based adjustments | Q38382772 |
| | Safety and effectiveness of MF-59 adjuvanted influenza vaccines in children and adults | Q38506829 |
| | Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies | Q38803189 |
| | Repeated annual influenza vaccination and vaccine effectiveness: review of evidence | Q39340731 |
| | Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies | Q41932605 |
| | A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60-85 years old) and very elderly (>85 years old) institutionalized subjects | Q41935331 |
| | Is the adjuvanted influenza vaccine more effective than the trivalent inactivated vaccine in the elderly population? Results of a case-control study | Q42203352 |
| | Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season | Q47135577 |
| | Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. | Q47150783 |
| | Uptake and effectiveness of influenza vaccine in those aged 65 years and older in the United Kingdom, influenza seasons 2010/11 to 2016/17 | Q57122379 |
| | Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019 | Q61810206 |
| | Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019 | Q64118690 |
| | Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019 | Q64243916 |
| | The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly | Q87232318 |
| P433 | issue | 2 | |
| P921 | main subject | influenza vaccine | Q383260 |
| P304 | page(s) | 173-179 | |
| P577 | publication date | 2019-10-22 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Protection provided by influenza vaccine against influenza-related hospitalisation in ≥65 year olds: Early experience of introduction of a newly licensed adjuvanted vaccine in England in 2018/19 | |
| P478 | volume | 38 | |